Wednesday, April 13, 2016 5:29:46 PM
loanranger Member Level Wednesday, 04/13/16 06:30:51 AM
Re: drkazmd65 post# 119889
Post #
119949
of 119989 Go
"Plenty of things "of substance" have been accomplished."
That's what you say. I don't agree. In the absence of a fancy degree I have to rely on what I think makes sense..."the proof is in the pudding" has proven to be not just sensible but a pretty decent investment guideline.
Tamiflu was approved in 1999. It is on the World Health Organization's List of Essential Medicines. The man in charge of the science at NanOviricides, Anil Diwan, used it perfectly appropriately as a reference point in a presentation at the PUBLIC MEETING ON NANOTECHNOLOGY MATERIALS IN FDA REGULATED PRODUCTS on Tuesday, October 10, 2006:
"in mouse studies we have shown that our drug....somewhere between 100 times better than Tamiflu in efficacy"
http://www.fda.gov/ohrms/dockets/dockets/06n0107/06n-0107-tr00001.pdf
In the 10 years since NNVC Chairman and President Diwan made that statement BILLIONS of dollars worth of Tamiflu (oseltamivir) have been sold. A year before Diwan spoke those words U.S. President George W. Bush requested that Congress fund US$1 billion for the production and stockpile of oseltamivir, after Congress had already approved $1.8 billion for military use of the drug.
There have been excuses galore for the failure of NNVC to bring the drug that was purportedly "somewhere between 100 times better than Tamiflu in efficacy" to market. The whole giant stinking pile of excuses doesn't add up to a decent explanation for that failure. We are constantly reminded of how long it takes to develop a drug to the point of approval. The company 10-K explains that "These clinical trials involve three separate phases that often overlap, can take many years to compile and are very expensive." The company has never progressed to the point where they even BEGAN that process in the case of a drug that was asserted to be 100 times better than the multi-billion dollar drug that it was compared to.
"Plenty of things "of substance" have been accomplished."
The most substantial company accomplishment to date has been its compilation of excuses for its failures with its archive of changes of direction running a close second.
The SwingTrade Portfolio was up 36.2% in 2014, 83.5% in 2013, and 546.6% since inception.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110307454
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM